Financial Performance - The company's revenue for Q1 2021 reached ¥5,810,550,826.94, representing a 43.51% increase compared to ¥4,048,898,332.23 in the same period last year[7] - Net profit attributable to shareholders was ¥81,829,097.05, up 60.51% from ¥50,980,357.36 year-on-year[7] - Basic and diluted earnings per share increased to ¥0.28, a rise of 64.71% from ¥0.17 in the same quarter last year[7] - Total operating revenue for the quarter reached ¥5,810,550,826.94, an increase of 43.51% compared to ¥4,048,898,332.23 in the previous period[14] - Net profit attributable to shareholders of the parent company was ¥81,829,097.05, up 60.51% from ¥50,980,357.36 in the same period last year[16] - The company reported a net profit increase in retained earnings to CNY 1,940,217,947.77 from CNY 1,858,388,850.74, reflecting an increase of approximately 4.39%[33] - The total profit for Q1 2021 was ¥202,056,848.63, up 83.5% from ¥110,159,970.12 in the previous year[40] Cash Flow - The net cash flow from operating activities improved significantly to ¥215,705,560.04, compared to a negative cash flow of ¥199,951,828.35 in the previous year, marking a 207.88% change[7] - The company achieved a net cash flow from operating activities of ¥215,705,560.04, a significant improvement from a negative cash flow of -¥199,951,828.35 in the previous period[16] - Cash inflow from operating activities totaled CNY 6,901,727,979.73, up from CNY 5,112,966,561.27, indicating a growth of 35.05%[48] - Cash outflow for purchasing goods and services was CNY 6,213,614,549.07, compared to CNY 4,958,946,989.21 in the previous period, an increase of 25.31%[48] - The company’s cash flow from operating activities was negatively impacted by increased payments to suppliers and employees, totaling CNY 6,686,022,419.69 in cash outflows[48] Assets and Liabilities - The total assets at the end of the reporting period were ¥14,051,071,264.83, a slight decrease of 0.58% from ¥14,133,717,238.25 at the end of the previous year[7] - The company’s total liabilities increased by 36.02% in other payables, amounting to ¥491,991,021.46, due to temporary advances to minority shareholders[14] - Total liabilities decreased to CNY 8,618,231,704.02 from CNY 8,809,686,211.29, reflecting a decline of approximately 2.17%[32] - The company's equity attributable to shareholders increased to CNY 3,710,764,843.40 from CNY 3,628,935,746.35, marking an increase of about 2.25%[33] - Current assets totaled CNY 12,510,203,493.83, slightly down from CNY 12,567,156,348.84, indicating a decrease of about 0.45%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 21,316[10] - The top shareholder, China Everbright Medical Health Industry Co., Ltd., holds 14.36% of the shares, totaling 41,876,431 shares[10] Operating Costs and Expenses - The total cost of operating reached ¥5,636,858,890.89, reflecting a 43.20% increase due to the corresponding rise in revenue[14] - The company’s sales expenses increased to ¥215,255,266.55, a rise of 40.5% compared to ¥153,147,544.00 in Q1 2020[39] - The company’s income tax expense increased by 101.02% to ¥57,169,021.73, reflecting the growth in profit[15] Investment and Development - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[39] - The company reported a significant increase in investment income, rising to ¥8,067,486.63 from ¥4,317,890.85 year-on-year[43] Other Financial Metrics - The weighted average return on equity was 2.23%, an increase of 0.75% compared to 1.48% in the previous year[7] - The company’s gross profit margin improved, with operating profit rising to ¥199,285,946.50, a 75.69% increase from ¥113,429,911.76 in the previous period[15] - Total comprehensive income for the first quarter was CNY 37,587,394.06, compared to CNY 25,664,651.35 in the previous period, representing a significant increase[45] - Basic and diluted earnings per share increased to CNY 0.13 from CNY 0.09, reflecting a growth of 44.44%[45]
嘉事堂(002462) - 2021 Q1 - 季度财报